UNITED STATES
     SECURITIES AND EXCHANGE COMMISSION

           Washington, D.C. 20549

               FORM 10-QSB

[X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES AND EXCHANGE ACT OF 1934
For the Quarter ended July 31, 1996

[   ]   TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE 
EXCHANGE ACT
For the transition period 			 to 			

     Commission file number     -    0-25614

       GLOBUS CELLULAR & USER PROTECTION, LTD.
       (formerly Leridges International, Inc.)
   (Exact name of Small Business Issuer in its charter)

       	NEVADA	                                 88-0228274
(State or other jurisdiction of	             (I.R.S. Employer
incorporation or organization)  	            Identification No.)


                      	1980 Windsor Road
	Kelowna, British Columbia, Canada	                V1Y 4R5	
	(Address of principal executive offices)	        (Zip Code)

      Registrant's Telephone number, including area code:
                        (604) 860-3130

Indicate by check mark whether the Registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities and Exchange 
Act of 1934 during the preceding twelve months (or such shorter period that 
the Registrant was required to file such reports), and (2) has been subject to 
file such filing requirements for the past thirty days.

Yes    x      No	
    -------      -------

Indicate the number of shares outstanding of each of the issuer's classes of 
common stock, as of the close of the period covered by this report:

           3,297,241 Shares of Common Stock ($.001 par value)
                             (Title of Class)

Transitional Small Business Disclosure Format (check one):      
Yes             No     x
   --------        --------	  




            GLOBUS CELLULAR & USER PROTECTION LTD.



PART I:	Financial Information

	ITEM 1 - Financial statements

	ITEM 2 - Management's' discussion and analysis of 
	financial condition and results of operations

PART II:	Other Information

	ITEM 6 - Exhibits and Reports on Form 8-K






                               PART I

Item 1. Financial Statements:

<TABLE>
         Globus Cellular and User Protection Ltd.
                       Balance Sheet
                       July 31, 1996
<CAPTION>
                           ASSETS
<S>                                                        <C>
Current assets:
  Cash                                                 $  136,982
  Accounts receivable, trade                              222,290
  Inventories                                              65,216
  Prepaid expenses                                         11,929
                                                      -----------
      Total current assets                                436,417

Property and equipment, at cost, less
  accumulated depreciation of $28,132                     132,872
                                                      -----------
                                                       $  569,289
                                                      ===========

            LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
  Mortgage payable - bank                               $  60,330
  Accounts payable                                         64,123
  Loans from stockholders                                 102,123
                                                       ----------
      Total current liabilities                         $ 226,576


Stockholders' equity:
 Preferred stock, $.001 par value,
  20,000,000 shares authorized,                                 -
 Common stock, $.001 par value,
  100,000,000 shares authorized,
  3,641,111 shares issued and
  outstanding                                               3,641
 Additional paid-in capital                             1,991,452
 Deficit                                               (1,402,780)
                                                       -----------
                                                          342,713
                                                       -----------
                                                       $  569,289
                                                       ===========
</TABLE>
     See accompanying notes to financial statements.


          Globus Cellular and User Protection Ltd.
                  Statements of Operations
  For the Three Months and Nine Months Ended July 31, 1996
<TABLE>
<CAPTION>                                   Three Months         Nine Months
                                                Ended                Ended
                                                July 31             July 31
                                                 1996                1996
                                               --------            --------
<S>                                              <C>                  <C>
Sales                                      $   516,860            $  563,368
Cost of sales                                  176,799               208,462
                                               --------            ---------
Gross profit (loss)                            340,061               354,906

Other costs and expenses:
 General and administrative                    333,461               597,178
 Research and development                        2,588                 7,178
                                              ---------             ---------
                                               336,049               604,356
                                              -----------           ---------
Income (loss) 
      from operations                            4,012              (249,450)

Other income and (expense):
 Interest income                                   518                 1,254
 Interest expense                               (2,252)               (5,650)
 Foreign exchange gain (loss)                    5,551                 2,763
                                              -----------           ----------
                                                 3,817                (1,633)
                                              -----------           ----------
Income (loss) 
      before income taxes                        7,829              (251,083)
Provision for income taxes                           -                     -
                                              -----------           ----------
  Net income (loss)                           $  7,829            $ (251,083
                                              ==========            ==========

Earnings (loss) per share:
 Net income (loss)                            $  (0.00)             $  (0.07)
                                              =========             =========

 Weighted average 
      shares outstanding                     3,578,606             3,390,489
                                             =========             =========
</TABLE>

             See accompanying notes to financial statements.


          


          Globus Cellular and User Protection Ltd.
                    Statements of Cash Flows
            For the Nine Months Ended July 31, 1996
<TABLE>
                                                              Nine Months
                                                                 Ended
                                                                July 31
                                                                 1996
                                                                --------
   <S>                                                           <C>
Net cash provided by (used in)
 operating activities                                        $  (95,417)


Cash flows from investing activities:
  Purchase of equipment                                         (11,800)
  Other                                                               -
                                                               ---------
  Net cash provided by (used in)
   financing activities                                         (11,800)

Cash flows from financing activities:
  Common stock sold for cash                                     96,850
  Increase (repayment) of officer loans                          (9,500)
                                                               ---------
  Net cash provided by (used in)
   financing activities                                          87,350
                                                               ---------
Increase (decrease) in cash                                     (19,867)
Cash and cash equivalents,
 beginning of period                                            156,849
                                                               ---------
Cash and cash equivalents,
 end of period                                                $ 136,982
                                                               =========
</TABLE>

     See accompanying notes to financial statements.




            Globus Cellular & User Protection, Ltd.
                 Notes to Financial Statements


Basis of presentation

The accompanying condensed unaudited financial statements have 
been prepared in accordance with generally accepted accounting 
principles for interim financial information and with the 
instructions to form 10-QSB. Accordingly, they do not include all 
of the information and footnotes required by generally accepted 
accounting principles for complete financial statements. In the 
opinion of management, all adjustments (consisting of normal 
recurring adjustments) considered necessary for a fair 
presentation have been included.

The results of operations for the periods presented are not 
necessarily indicative of the results to be expected for the full 
year. The accompanying financial statements should be read in 
conjunction with the Company's form 10-KSB filed for the year 
ended October 31, 1995.

Income (loss) per share was computed using the weighted average 
number of common shares outstanding.

During the period ended July 31, 1996 the Company issued 64,567 
shares of its common stock pursuant to the exercise of warrants 
for cash aggregating $96,850.  In addition, during the period, 
The Company issued 343,870 shares of its common stock as 
compensation to consultants, pursuant to a registration statement 
on Form S-8, filed in January 1996.  The shares were valued at 
the market price of the common stock on the date the issuance of 
shares was authorized.  The aggregate amount charged to 
operations for these transactions was $438,238 of which $188,638 was 
charged to operations for the nine months ended July 31, 1996.   Form S-8 
shares issued and issuable (95,000 shares valued at $118,750) to a financial 
consultant are for a service contract with a two year term beginning April 
15, 1996.   Shares issued prior to the performance of contracted services are 
accounted for as unpaid subscriptions to common stock.

The required financial information for the nine months ended July 
31, 1995 is not included herein as the information necessary to 
prepare these financial statements is not available.

Prior to the quarter ended July 31, 1996, the Company was 
considered to be in its development stage.










GLOBUS CELLULAR & USER PROTECTION LTD.

PART I (cont.)


Item 2. Management's Discussion and Analysis of Financial 
Condition and Results of Operations:

Capital Resources and Liquidity.

The Company has emerged (October 18, 1994) from a Chapter 11 
bankruptcy proceeding which it filed in March, 1993.  Since the date of 
filing of the bankruptcy proceeding, Company had been inactive and had 
been engaged in no business.  The acquisition of the assets of Globus 
Cellular & User Protection Ltd., a Canadian corporation, put the Company 
into the position of starting a new business.

Globus Cellular & User Protection Ltd. (Canada), a British Columbia 
corporation, was incorporated on July 28, 1993.  Thereafter, the 
corporation acquired the patent rights to the cellular phone product (the 
"C.U.P"), which it subsequently sold to Company pursuant to the Plan of 
Reorganization, filed and approved by the U.S. Bankruptcy Court.

The Company completed a private sale of 500,000 common shares for 
$500,000 in the third and fourth quarter of fiscal 1995 and has settled all 
debts, including payment on the License of Technology to January 1, 1995.   
The payment on License of Technology for the first six months of 1996 was 
rescheduled by Dr. Bickert and the Company due to the expense being 
incurred by the Company to secure world-wide patent protection on its 
patent co-operation treaty filing. Additionally, the Company commenced 
reselling of x-ray products (film, shielding garments, x-ray machines and 
accessories) to generate an immediate input of additional revenues.  The 
Company believes that the proceeds of the sale of Common Stock and the 
exercise of outstanding warrants will be sufficient to allow it to operate with 
minimum revenues over the next twelve (12) months.   However, such 
proceeds will not allow the Company to commence full scale operations 
regarding its planned C.U.P. product.

Long-term liquidity will be dependent on anticipated future revenue.   
Additionally, the Company shall pursue a registration of its Common 
Shares and Class "A" Warrants and will, in part, rely on the subsequent 
exercise of said Warrants.   Any additional funds raised and any revenues 
received from sale of Company's products will enable Company to expand 
its plan of operations by increasing its production and expanding its product 
line.

During the period ended July 31, 1996, the Company issued 64,567 shares 
of its restricted common stock pursuant to the exercise of warrants for cash 
aggregating $96,850.   Additionally, the Company repaid a portion of its 
shareholder loans ($9,500) resulting in net cash provided by financing 
activities of $87,350 for the nine months ended July 31, 1996.


The Company acquired plant and equipment valued at $11,800 for the 
period ended July 31, 1996.   This resulted in net cash used in investing 
activities of $11,800.   The Company does not anticipate purchasing any 
additional plant or significant equipment and does not expect any significant 
changes in the number of its employees, nor does Company expect to 
perform any material product research and development during the next 
twelve (12) months.

The Company is not presently aware of any known trends, events or 
uncertainties that may have a material impact on net sales, revenues or 
income from its operations.  However, Company's product is new in the 
market and there are not assurances it can be marketed successfully and/or 
profitably.

The management of Company is led by Dr. Paul F. Bickert, Dr. Ronald 
Armstrong and Bernard Penner.  Dr. Bickert and Dr. Armstrong are both 
doctors of chiropractic who have studied the principles, practice and use of 
X-rays and have a thorough understanding of the nature of U.H.F. 
radiation and the potential health risks to persons exposed to radiation over 
long period of time.  Mr. Penner owns and operates a large and highly 
successful construction business and will provide quality control and 
management skills to Company, which are necessary to develop a labor 
force to manufacture and market Company's products.

Results of Operations.	

The Company experienced a net loss from operating activities of $249,450 
for the nine months ended July 31, 1996.   Total Sales were $516,860 for 
the three months ended July 31, 1996 and $563,368 for the nine months 
ended July 31, 1996.   Cost of Sales, however, were $176,799 and 
$208,462 for the same periods respectively.  Substantial selling, general 
and administrative expenses of $333,461 were incurred for the three months 
ended July 31, 1996 and $597,178 for the nine months ended July 30, 
1996 due to the Company's increased operations.   The Company expended 
$2,588 on  research and development expenses for the three months ended 
July 31, 1996 and $7,178 for the nine months ended July 31, 1996 due to 
the stage of development of the C.U.P. product and commencement of sale 
of said product.   

The Company experienced a net loss from operating activities of $706,368 
for the year ended October 31, 1995.   Total Sales increased from $4,411 
for the year ended October 31, 1995 to $40,980 for the year ended October 
31, 1995 due to increased operations.  However, Cost of Sales increased 
from $6,438 to $22,045 for those same periods respectively.   Selling, 
general and administrative expenses increased substantially to $690,600 for 
the year ended October 31, 1995 compared to $224,982 for the same period 
in 1994 due to the Company's increased operations.   Research and 
development expenses decreased from $148,573 for the year ended October 
31, 1994 to $24,476 for the same period in 1995 due to the stage of 
development of the C.U.P. product and commencement of sale of said 
product.

The Company issued stock options for officer services of $272,679 for the 
year ended October 31, 1995.    Depreciation for the year ended October 31, 
1995 was $12,421.   For the year ended October 31, 1995, the Company 
experienced an increase in accounts receivable of $6,008, an increase in 
inventory of $31,570, and increase in prepaid expenses of $23,815 and a 
decrease in accounts payable of $10,544, all due to increased operations.  
Foreign exchange translation adjustment was $1,049 for the year ended 
October 31, 1995.   These items resulting in net cash used in operating 
activities of $444,526 for the year ended October 31, 1995.

The Company experienced a net loss from operating activities of $375,335 
for the Ten Months Ended October 31, 1994 compared to a net loss of 
$70,627 for the year ended December 31, 1993.   This increased loss is 
mainly a result of the selling, general, administrative costs of consulting of 
$48,137 and legal fees of $27,685 associated with the merger and royalty 
and licensing fees of $87,183.   Total Sales decreased for the Ten months 
ended October 31, 1994 to $4,411 from $25,534 for the year ended 
December 31, 1995 due to the Company's decision to cease the distribution 
of its products by direct sale and instead engage in extensive research to 
demonstrate effectiveness of its product and to make necessary 
modifications to increase said effectiveness..  Additionally, Cost of Sales 
have also decreased from $18,415 to $6,438 for those same periods 
respectively.   Selling, general and administrative expenses increased 
substantially to $225,718 for the six months ended July 31, 1995 compared 
to $14,454 for the year ended December 31, 1994 mainly as result of 
consulting of $48,137 and legal fees of $27,685 associated with the merger 
and royalty and licensing fees of $87,183.   Research and development 
expenses increased from $63,765 for the year ended December 31, 1993 to 
$148,573 for the ten months ended October 31, 1993 due to the stage of 
development of the C.U.P. product and commencement of sale of said 
product.






            GLOBUS CELLULAR & USER PROTECTION LTD.

                            PART II


Item 6. Exhibits and Reports on Form 8-K  

	(a)	Exhibits (numbered in accordance with Item 601 of 
		Regulation S-K)

		None

	(b)	Reports on Form 8-K
		
		None


                              SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the 
registrant has duly caused this report to be signed on its behalf by the 
undersigned thereunto duly authorized.

Date:	October 25, 1996		 	         /s/  Dr. Paul F. Bickert
                                   ----------------------------------	
                             						Dr. Paul F. Bickert, President